跳至主要内容
临床试验/ITMCTR2024000098
ITMCTR2024000098尚未招募1 期

A Clinical Study on the Impact of Dao Yin on Cardiopulmonary Function in Ovarian Cancer Patients Based on the Theory of Qi and Blood

Xiyuan Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 至 70(—)
性别
Female

入选标准

  • •(1) Meets the above diagnostic criteria;
  • •(2) Normal levels of tumor markers such as CA125, CA199, CEA, HE4, etc., and patients are currently in a progression-free survival period;
  • •(3) Borg dyspnea score between 11 and 15;
  • •(4) Age between 45 and 70;
  • •(5) Willing to participate and sign the informed consent form either by themselves or through a legal guardian.

排除标准

  • •(1) Patients with contraindications to exercise rehabilitation;
  • •(2) Patients with severe chronic obstructive pulmonary disease (COPD) classified as Grade II-IV according to the Chinese Medical Association's Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease;
  • •(3) Ovarian cancer is not the primary tumor and is combined with an untreated secondary malignant tumor;
  • •(4) Patients with stage III-V chronic kidney disease;
  • •(5) Patients with mobility difficulties such as bone metastasis, fractures, severe joint deformities, etc., which prevent the completion of the exercise therapy plan;
  • •(6) Berg Balance Scale score less than 40;
  • •(7) Montreal Cognitive Assessment (MoCA) score less than 27.

研究者

相似试验